JP2018046827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018046827A5 JP2018046827A5 JP2017195120A JP2017195120A JP2018046827A5 JP 2018046827 A5 JP2018046827 A5 JP 2018046827A5 JP 2017195120 A JP2017195120 A JP 2017195120A JP 2017195120 A JP2017195120 A JP 2017195120A JP 2018046827 A5 JP2018046827 A5 JP 2018046827A5
- Authority
- JP
- Japan
- Prior art keywords
- bacterium
- gene
- antibody
- trehalose
- endogenous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11182643 | 2011-09-23 | ||
| EP11182643.4 | 2011-09-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014531243A Division JP6329903B2 (ja) | 2011-09-23 | 2012-09-21 | 改変されたグラム陽性菌及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018046827A JP2018046827A (ja) | 2018-03-29 |
| JP2018046827A5 true JP2018046827A5 (enExample) | 2018-07-05 |
| JP6669703B2 JP6669703B2 (ja) | 2020-03-18 |
Family
ID=47040665
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014531243A Active JP6329903B2 (ja) | 2011-09-23 | 2012-09-21 | 改変されたグラム陽性菌及びその使用 |
| JP2017195120A Expired - Fee Related JP6669703B2 (ja) | 2011-09-23 | 2017-10-05 | 改変されたグラム陽性菌及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014531243A Active JP6329903B2 (ja) | 2011-09-23 | 2012-09-21 | 改変されたグラム陽性菌及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9347036B2 (enExample) |
| EP (2) | EP2758513B1 (enExample) |
| JP (2) | JP6329903B2 (enExample) |
| KR (1) | KR102028771B1 (enExample) |
| CN (1) | CN103917639B (enExample) |
| AU (2) | AU2012311479B2 (enExample) |
| BR (1) | BR112014006883A8 (enExample) |
| CA (2) | CA3131722A1 (enExample) |
| DK (1) | DK2758513T3 (enExample) |
| ES (1) | ES2676270T3 (enExample) |
| HU (1) | HUE038336T2 (enExample) |
| RU (1) | RU2653757C2 (enExample) |
| WO (1) | WO2013041673A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2758513B1 (en) * | 2011-09-23 | 2018-05-16 | Intrexon Actobiotics NV | Modified gram positive bacteria and uses thereof |
| DK2758512T3 (en) | 2011-09-23 | 2018-07-23 | Intrexon Actobiotics Nv | MODIFIED GRAM POSITIVE BACTERIES AND APPLICATIONS THEREOF |
| US10696974B2 (en) | 2014-12-23 | 2020-06-30 | Ilya Pharma Ab | Methods for wound healing |
| JP7292877B2 (ja) | 2016-01-14 | 2023-06-19 | イントレクソン・アクトバイオテイクス・エヌブイ | １型糖尿病を処置するための組成物および方法 |
| RU2768027C2 (ru) * | 2016-09-02 | 2022-03-23 | Интрексон Актобиотикс Н.В. | Генетически модифицированные бактерии, стабильно экспрессирующие ил-10 и инсулин |
| KR102348734B1 (ko) * | 2016-09-13 | 2022-01-07 | 인트랙슨 액토바이오틱스 엔.브이. | 점막부착성 미생물 |
| IT201600122724A1 (it) * | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| US20210380994A1 (en) * | 2018-10-09 | 2021-12-09 | Daniela Keilberg | Lactococcus lactis expression system for delivering proteins efficacious for the treatment of epithelial barrier function disorders |
| CN114854807B (zh) * | 2022-05-23 | 2024-05-17 | 中国科学院微生物研究所 | 一种生产海藻糖六磷酸的方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9006400D0 (en) | 1990-03-22 | 1990-05-23 | Ciba Geigy Ag | Bacterial vectors |
| US6277969B1 (en) | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| IT1270123B (it) | 1994-10-05 | 1997-04-28 | Dompe Spa | Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia |
| GB9521568D0 (en) | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
| US6033376A (en) | 1998-09-30 | 2000-03-07 | Allergan Sales, Inc. | Wound shaper sleeve |
| EP1123314B1 (en) | 1998-10-20 | 2004-02-18 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Use of a cytokine-producing lactococcus strain to treat colitis |
| CA2377107C (en) | 1999-07-05 | 2013-04-23 | Wolfgang Christian Hans | Delivery of trefoil peptides |
| AT407730B (de) | 2000-01-14 | 2001-05-25 | Hoerbiger Hydraulik | Betätigungsanordnung für schwenkbare teile an fahrzeugen |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| AU2002314040B2 (en) | 2001-05-03 | 2007-06-28 | Intrexon Actobiotics Nv | Self-containing lactococcus strain |
| CA2506031A1 (en) | 2002-11-15 | 2004-06-03 | Vib Vzw | Self-containing lactobacillus strain comprising a thya mutation and therapeutic applications thereof |
| EP2223609A1 (en) * | 2004-02-24 | 2010-09-01 | Chr. Hansen A/S | Frozen lab culture of individual frozen pellets |
| EP1751270A1 (en) | 2004-05-18 | 2007-02-14 | VIB vzw | Self-containing lactobacillus strain |
| DK1789529T3 (da) * | 2004-08-20 | 2013-11-11 | Actogenix Nv | Fremgangsmåde til forbedring af konserveringen af lactococcus |
| ES2626610T3 (es) | 2005-08-30 | 2017-07-25 | Intrexon Actobiotics Nv | Bacterias de ácido láctico productoras del anti-TNF alfa para el tratamiento de la enfermedad inflamatoria intestinal |
| ES2596855T3 (es) | 2005-11-29 | 2017-01-12 | Intrexon Actobiotics Nv | Inducción de tolerancia mucosa a antígenos |
| AU2007247137A1 (en) | 2006-05-02 | 2007-11-15 | Actogenix N.V. | Microbial intestinal delivery of obesity related peptides |
| CA2672229A1 (en) | 2006-12-14 | 2008-06-19 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| RU2495129C2 (ru) | 2007-01-12 | 2013-10-10 | Актогеникс Н.В. | ПРОМОТОРЫ Lactococcus И ИХ ПРИМЕНЕНИЕ: |
| JP2010516269A (ja) | 2007-01-25 | 2010-05-20 | アクトジェニックス・エヌブイ | 抗原の粘膜送達による免疫疾患の治療 |
| DK3181682T3 (da) | 2008-09-29 | 2021-07-05 | Intrexon Actobiotics Nv | Reduceret kolonisering af mikrober på slimhinden |
| RU2393214C1 (ru) * | 2009-01-29 | 2010-06-27 | Общество с ограниченной ответственностью "ИнноПроб"(ООО"ИнноПроб") | Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus nkjc, штамм lactobacillus acidophilus jch, штамм lactobacillus acidophilus kaa |
| JP5897459B2 (ja) | 2009-04-30 | 2016-03-30 | イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ | 乳酸菌のフリーズドライのための凍結保護剤 |
| DK2758512T3 (en) * | 2011-09-23 | 2018-07-23 | Intrexon Actobiotics Nv | MODIFIED GRAM POSITIVE BACTERIES AND APPLICATIONS THEREOF |
| EP2758513B1 (en) * | 2011-09-23 | 2018-05-16 | Intrexon Actobiotics NV | Modified gram positive bacteria and uses thereof |
-
2012
- 2012-09-21 EP EP12773253.5A patent/EP2758513B1/en active Active
- 2012-09-21 KR KR1020147010661A patent/KR102028771B1/ko not_active Expired - Fee Related
- 2012-09-21 EP EP18172371.9A patent/EP3382006B1/en active Active
- 2012-09-21 BR BR112014006883A patent/BR112014006883A8/pt not_active Application Discontinuation
- 2012-09-21 CA CA3131722A patent/CA3131722A1/en not_active Abandoned
- 2012-09-21 JP JP2014531243A patent/JP6329903B2/ja active Active
- 2012-09-21 CN CN201280053876.1A patent/CN103917639B/zh not_active Expired - Fee Related
- 2012-09-21 CA CA2848471A patent/CA2848471C/en active Active
- 2012-09-21 WO PCT/EP2012/068634 patent/WO2013041673A1/en not_active Ceased
- 2012-09-21 HU HUE12773253A patent/HUE038336T2/hu unknown
- 2012-09-21 US US14/346,488 patent/US9347036B2/en active Active
- 2012-09-21 ES ES12773253.5T patent/ES2676270T3/es active Active
- 2012-09-21 RU RU2014116230A patent/RU2653757C2/ru active
- 2012-09-21 AU AU2012311479A patent/AU2012311479B2/en not_active Ceased
- 2012-09-21 DK DK12773253.5T patent/DK2758513T3/en active
-
2016
- 2016-01-21 US US15/003,426 patent/US9982228B2/en active Active
-
2017
- 2017-10-05 JP JP2017195120A patent/JP6669703B2/ja not_active Expired - Fee Related
- 2017-11-29 AU AU2017268593A patent/AU2017268593B9/en not_active Ceased
-
2018
- 2018-04-23 US US15/959,705 patent/US10519418B2/en active Active
-
2019
- 2019-12-13 US US16/713,737 patent/US10793825B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018046827A5 (enExample) | ||
| AU2016201489B2 (en) | Cryoprotectants for freeze drying of lactic acid bacteria | |
| JP2019530446A5 (enExample) | ||
| RU2021135949A (ru) | Мукоадгезивный микроорганизм | |
| JP6669703B2 (ja) | 改変されたグラム陽性菌及びその使用 | |
| CA2234941A1 (en) | Delivery of biologically active polypeptides | |
| EP1841875B1 (en) | Controlled production and delivery of biologically active agents by gut bacteria | |
| JP6117212B2 (ja) | 改変されたグラム陽性菌及びその使用 | |
| EP2578090A1 (en) | New probiotic strains | |
| EP2075332A1 (en) | Cytokine production regulator gene and use thereof | |
| Rottiers et al. | Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis | |
| AU2016235674A1 (en) | Transformant used for losing weight and reducing fat, construction method for transformant, and application of transformant | |
| Chen et al. | Advances in the study of lactic acid bacteria as vehicles for the in vivo delivery of bioactive substances. | |
| CN121022698A (zh) | 分泌性表达鸡igf-1的重组植物乳杆菌及其构建方法和应用 | |
| HK1259783B (en) | Modified gram positive bacteria and uses thereof | |
| HK1259783A1 (en) | Modified gram positive bacteria and uses thereof | |
| KR20140067711A (ko) | M 세포 특이 표적 펩타이드 cks9 서열이 도입되어 t세포 성장인자 단백질을 분비하는 신규한 형질전환 유산균 및 그의 용도 |